omalizumab
SpainDrugs containing this active substance
-
It is used for the treatment of severe allergic asthma in adults and children (from 6 years of age), chronic rhinosinusitis with nasal polyps in adults, and chronic spontaneous urticaria in adults and adolescents (from 12 years of age).
Form: solution for injection in pre-filled pen
Active substance Dosage omalizumab 150 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used for the treatment of severe allergic asthma in adults and children aged 6 years and older, chronic rhinosinusitis with nasal polyps in adults, and chronic spontaneous urticaria in adults and adolescents aged 12 years and older.
Form: solution for injection in a pre-filled syringe
Active substance Dosage omalizumab 150 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used to treat severe allergic asthma in adults, adolescents, and children aged 6 years and older who are already using other medications, and to treat chronic rhinosinusitis with nasal polyps in adults aged 18 years and older.
Form: solution for injection in a pre-filled syringe
Active substance Dosage omalizumab 75 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used for the treatment of severe allergic asthma in adults and children (from 6 years of age), chronic rhinosinusitis with nasal polyps in adults (from 18 years of age), and chronic spontaneous urticaria in adults and adolescents (from 12 years of age).
Form: solution for injection in a pre-filled syringe
Active substance Dosage omalizumab 150 mg Manufacturer: Novartis Europharm Limited
-
It is used for the treatment of severe allergic asthma in adults, adolescents, and children aged 6 years and older whose symptoms are not controlled with other medications. It is also used in adults (over 18 years old) to treat chronic rhinosinusitis with nasal polyps.
Form: solution for injection in a pre-filled syringe
Active substance Dosage omalizumab 75 mg Manufacturer: Novartis Europharm Limited